Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Boakye A. Boatin"'
Publikováno v:
Infectious Diseases of Poverty, Vol 8, Iss 1, Pp 1-5 (2019)
Abstract In a recent article we discussed the feasibility of onchocerciasis elimination in Africa by 2025. We expressed concern that elimination may be impeded by failure to build on the lessons learned in the African onchocerciasis control programme
Externí odkaz:
https://doaj.org/article/f045db1bc61448eca67b2cb222eda7d9
Publikováno v:
Infectious Diseases of Poverty, Vol 7, Iss 1, Pp 1-11 (2018)
Abstract Background Onchocerciasis is found predominantly in Africa where large scale vector control started in 1974. Registration and donation of ivermectin by Merck & Co in 1987 enabled mass treatment with ivermectin in all endemic countries in Afr
Externí odkaz:
https://doaj.org/article/aece7ee2f5bf430e9eb8dfb3b9a0dbc4
Publikováno v:
Human and Animal Filariases. :307-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a381fd2dc493cb34963a3203b0a5c32
https://doi.org/10.1002/9783527823413.ch12
https://doi.org/10.1002/9783527823413.ch12
Autor:
Maimouna Diop Ly, Joseph Okeibunor, Uche V. Amazigo, Andy Crump, Sunday Isiyaku, Chukwu Okoronkwo, Boakye A. Boatin, Stephen G. A. Leak, Honorat G. M. Zouré
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 3, p e0009088 (2021)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
The neglected tropical diseases (NTDs) affect hundreds of millions of people, predominantly in rural, often difficult-to-access areas, poorly served by national health services. Here, we review the contributions of 4.8 million community-directed dist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2916f5ac75a85b2105a9f0957c3980a9
https://doaj.org/article/e21e6253ddd942f7b055b90318ac0258
https://doaj.org/article/e21e6253ddd942f7b055b90318ac0258
Autor:
John O. Gyapong, Boakye A. Boatin
This fully updated and expanded second edition provides an overview of the major neglected tropical diseases (NTDs) occurring in sub-Saharan Africa, such as leishmaniasis, buruli ulcer, schistosomiasis and many more. The well-structured chapters expl
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 4, p e1603 (2012)
In this paper, the Disease Reference Group on Helminth Infections (DRG4), established in 2009 by the Special Programme for Research and Training in Tropical Diseases (TDR), with the mandate to review helminthiases research and identify research prior
Externí odkaz:
https://doaj.org/article/c0c8700c225b474f91a8294d95d0ee2a
Autor:
Martin Walker, Mark P Little, Karen S Wagner, Edoh W Soumbey-Alley, Boakye A Boatin, María-Gloria Basáñez
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 3, p e1578 (2012)
The parasite Onchocerca volvulus has, until recently, been regarded as the cause of a chronic yet non-fatal condition. Recent analyses, however, have indicated that in addition to blindness, the parasite can also be directly associated with human mor
Externí odkaz:
https://doaj.org/article/87af443b5e114252ad80100da7b5a9bc
Autor:
Pierre Guillet, Y. Bissan, A. Seketeli, H. Agoua, E. S. Alley, Boakye A. Boatin, E. M. Samba, D. Quillevere, L. K. B. Akpoboua
Publikováno v:
Trente ans de lutte contre l’onchocercose en Afrique de l’Ouest. Traitements larvicides et protection de l’environnement ISBN: 9782709915236
As part of the WHO Onchocerciasis Control Programme in West Africa (OCP), the attack phase of operations in the Niger basin in Guinea began in 1989 with the simultaneous use of ivermectin and vector control. Larvicide applications coupled with annual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f86926829438d4a61eea3a365ba1a6
http://books.openedition.org/irdeditions/29073
http://books.openedition.org/irdeditions/29073
Publikováno v:
Infectious Diseases of Poverty
Infectious Diseases of Poverty, Vol 8, Iss 1, Pp 1-5 (2019)
Infectious Diseases of Poverty, Vol 8, Iss 1, Pp 1-5 (2019)
In a recent article we discussed the feasibility of onchocerciasis elimination in Africa by 2025. We expressed concern that elimination may be impeded by failure to build on the lessons learned in the African onchocerciasis control programmes and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b560a3ee58a6b0ee9477856ee5a865ed
https://doi.org/10.1186/s40249-019-0574-0
https://doi.org/10.1186/s40249-019-0574-0
Publikováno v:
Infectious Diseases of Poverty
Infectious Diseases of Poverty, Vol 7, Iss 1, Pp 1-11 (2018)
Infectious Diseases of Poverty, Vol 7, Iss 1, Pp 1-11 (2018)
Background Onchocerciasis is found predominantly in Africa where large scale vector control started in 1974. Registration and donation of ivermectin by Merck & Co in 1987 enabled mass treatment with ivermectin in all endemic countries in Africa and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::494bc83104ce43f9a1bf603516e4a7b6
http://europepmc.org/articles/PMC6029117
http://europepmc.org/articles/PMC6029117